McKesson posts strong Q4, fiscal year results
McKesson’s pharmaceutical and specialty solutions segment saw revenue increase 13% over Q4 2019, totaling $46.3 billion, and full-year revenue for the segment rose 9% over the prior fiscal year, totaling $183.3 billion.